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Abstract
Objective To determine the pooled effect of exposure to one of 11
specialist palliative care teams providing services in patients’ homes.
Design Pooled analysis of a retrospective cohort study.
Setting Ontario, Canada.
Participants 3109 patients who received care from specialist palliative
care teams in 2009-11 (exposed) matched by propensity score to 3109
patients who received usual care (unexposed).
Intervention The palliative care teams studied served different
geographies and varied in team composition and size but had the same
core team members and role: a core group of palliative care physicians,
nurses, and family physicians who provide integrated palliative care to
patients in their homes. The teams’ role was to manage symptoms,
provide education and care, coordinate services, and be available without
interruption regardless of time or day.
Main outcome measures Patients (a) being in hospital in the last two
weeks of life; (b) having an emergency department visit in the last two
weeks of life; or (c) dying in hospital.
Results In both exposed and unexposed groups, about 80% had cancer
and 78% received end of life homecare services for the same average
duration. Across all palliative care teams, 970 (31.2%) of the exposed
group were in hospital and 896 (28.9%) had an emergency department
visit in the last two weeks of life respectively, compared with 1219
(39.3%) and 1070 (34.5%) of the unexposed group (P<0.001). The
pooled relative risks of being in hospital and having an emergency
department visit in late life comparing exposed versus unexposed were
0.68 (95% confidence interval 0.61 to 0.76) and 0.77 (0.69 to 0.86)
respectively. Fewer exposed than unexposed patients died in hospital
(503 (16.2%) v 887 (28.6%), P<0.001), and the pooled relative risk of
dying in hospital was 0.46 (0.40 to 0.52).
ConclusionsCommunity based specialist palliative care teams, despite
variation in team composition and geographies, were effective at reducing
acute care use and hospital deaths at the end of life.
Introduction
Home based palliative care teams are meant to help patients
manage symptoms, improve quality of life, and prevent
avoidable hospitalisations, which are documented issues at end
of life.1-3Moreover, policymakers internationally want to deliver
integrated palliative care in the home and community, since
many patients prefer to be cared for at home, community care
is often less expensive than hospital care, and acute care
hospitals are overwhelmed.4 5 However, policy makers are
unsure of optimal models of care delivery based on
interdisciplinary teams. Although studies have evaluated
specialist palliative care teams in hospitals,6-8 only nine
randomised controlled trials specifically investigated specialist
teams in the community.9-17 The community based teams studied
in these trials involved a core group of interdisciplinary team
members, specifically palliative care physicians, nurses, and
family physicians who provide integrated palliative care to
patients in their homes. A common role of the teams was to
manage symptoms, provide education, coordinate care, and
provide additional or enhanced support and care. Teams were
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also available to care providers, patient, and family 24/7
(available without interruption regardless of time or day).
However, variations existed within core team members, such
as the extent of involvement of the family physicians, ranging
from minimal (such as a single consultation) to extensive (such
as substitution of usual family physician with palliative care
physician) depending on the team. In addition, teams may have
included other members such as a psychosocial counsellor or
social worker, varying their team compositions.
While the nine community based trials of specialist palliative
care teams consistently reported improved symptom
management, satisfaction, and quality of life,9-12 14-16 the evidence
for reducing hospital and emergency department visits was
mixed. Three trials demonstrated that patients cared for by
specialist teams had significantly fewer hospitalisations or
emergency department visits compared with usual care,10 11 15
whereas four trials did not.9 13 14 16 Three trials also found that
specialist teams significantly increased the likelihood of patients
dying at home,10 13 15 but one meta-analysis (examining
community based, specialist, palliative care teams providing
nursing services) found inconclusive evidence for the same
outcome.18 Variations among the teams in the nine
trials—including the health financing system, team size, and
team composition—may have contributed to themixed evidence,
but this has not been researched. Thus, research has not clearly
explained why some teams reduced acute care use while others
did not.
A natural experiment exists in Ontario, Canada, where several
regions have independently developed their own community
based, specialist, palliative care teams. These different palliative
care teams serve different catchment areas, vary in team
composition, but have the same core team members and are
within the same health financing system. Thus, they represent
a unique opportunity to assess the generalisability of
effectiveness of specialist palliative care teams in real world
conditions. Specifically, this study investigates the pooled
association of reducing use of acute care late in life and hospital
death among those exposed to one of several community based
specialist palliative care teams compared with usual care in the
community.
Methods
Study design
Linking administrative databases, we conducted a retrospective
cohort study in Ontario, Canada, during 2009-11. To reduce
confounding due to measured covariates when estimating the
effect of exposure to a specialist team, patients treated by each
of 11 teams were matched to similar patients not treated by any
team (usual care) using propensity score methods. The effect
of each of the 11 teams was estimated separately and also pooled
to obtain an overall team effect.
Study setting
Most home based palliative care in Ontario is delivered by the
public homecare system without involvement from palliative
care teams (referred to in this study as usual care). Usual care
can be fragmented, inconsistent, and of variable quality.19 On
referral to the public homecare agency, a patient is identified
as needing palliative care by a case manager. The homecare
agency coordinates care and contracts the delivery of services,
mainly nursing and personal support at end of life, to multiple
service provider organisations.20 Patients are often treated by
different service provider organisations with little coordination
between them. The palliative care training of the homecare
workers is highly variable.21 In Ontario 68% of cancer patients
receive some homecare services in the last six months of life,22
and 62% of those patients received end of life homecare services
at some point, two thirds for less than three months before
death.23 Contacting providers and receiving care after office
hours or on weekends is difficult.
Most family physicians provide care independently of homecare
and rarely make home visits.24Research has shown that, among
Ontarian cancer patients, 85% saw a family physicians at least
once while receiving end of life homecare services, for a median
of 0.75 family physician visits/week.25 Further, 24% had a
physician house call in the last two weeks of life.22 However,
family physician training in palliative care is highly variable,
and palliative care physicians are involved in care in an uneven
or limited capacity, since most are employed in a hospital setting
to serve in an inpatient palliative care unit rather than in the
community. Therefore, “usual care” in Ontario is a poorly
integrated system.
Ontario only has about 24 residential hospices for the entire
province, each with about 10 beds. Thus, there is limited
capacity in the system to accommodate patients dying in a
residential hospice bed. Indeed, the rate of hospital deaths in
Ontario is 65%,26 compared with 45% in the US27 and 65% in
the UK.28
In contrast, in regions where specialist palliative care teams
were available, patients were referred to a team by a provider
from the hospital, family physician’s office, cancer centre, or
homecare agency based on clinical factors, functional decline,
and expected prognosis of less than six months. The specialist
team would then visit the home to determine eligibility, care
plan, and how often to visit and call the patient afterwards,
caring for them until death.
Selection criteria
Intervention teams and exposed patients
To identify Ontario teams for inclusion in our study, we included
formal palliative care specialist teams that met the following
criteria: (a) provided interdisciplinary, home based, palliative
care; (b) were the only such team in their respective region; (c)
had little or no change in staffing between 2009 until 2012; (d)
had broad admission criteria not limited to one disease (such as
cancer); (e) admitted more than 50 patients a year; (f) were
available to patients 24/7; and (g) had the same core members
of their team as the past randomised trials. However, team size,
team members, geography, and referral capacity could vary.
Across the province, 11 teams met these criteria, and their
patients served were eligible for inclusion. Patients were
excluded if they were alive after fiscal year 2011, were <18
years old, or had an invalid or missing provincial health
insurance number.
Comparison regions and unexposed patients
We a priori chose two approaches to identify control groups
exposed to usual care.
Historical—For teams beginning after 2009 (teams 1 to 6),
exposed decedents were assigned a match from the pool of
decedents within the same health region in an earlier period,
fiscal years 2007-09, so factors related to health system
delivery were the same. No other major policy or
organisational changes related to palliative care occurred
between 2007 and 2011 in these regions, except for the team
development after 2009, confirmed by policy review and
interviews with the team administrators.
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Geographical—For teams starting before 2009 (teams 7 to
11) exposed decedents were assigned a match from the pool
of decedents from a neighbouring region that was similar in
size, geography, and access to services during the same study
period (fiscal years 2009-11) but did not have a specialist
palliative care team available.. This second approach was
used because, based on anecdotal evidence from clinical
providers of these mature teams, the usual care system in
their region was “contaminated”: teams had developed
sufficiently to build key relationships and increase palliative
care knowledge in usual care providers, allowing them to
handle more basic palliative care needs on their own—which
meant the teams were getting referred more complex and
symptomatic patients. This created a selection bias in the
unexposed cohort pool within their regions which were
unmeasured. Thus, we chose a similarly resourced
neighbouring region that did not have a specialist team, to
reduce bias and keep the control group’s exposure to “usual
care” consistent across teams for generalisability.
Data sources
Each team provided a list of patients admitted to the intervention
team during fiscal years 2009-11. This list was linked tomultiple
administrative databases via a unique, encrypted, provincial
health insurance number.We used the provincial Vital Statistics
database to confirm date of death, age at death, and sex. We
used the Discharge Abstract Database to determine hospital
admissions or hospital death (which excluded the hospital’s
palliative care unit), as well as comorbidity score weight, and
presence of cancer condition.We also usedNational Ambulatory
Care Reporting System to determine emergency department
visits. We used the Home Care Database to determine dates of
publically funded homecare service use and service type.
Statistics Canada census data were used to determine region
and rurality, using postal code data.
Propensity score matching
To reduce selection bias, we used propensity score matching to
assemble a group of unexposed patients who were similar to
each of the intervention groups.We created 11matched cohorts,
each consisting of pairs of exposed patients and unexposed
subjects who were selected from an appropriate control
population. The propensity score is each individual’s probability
of using a specialist team given the values of his
pre-intervention, baseline covariates.Matching on the propensity
score can estimate the effect of the intervention, which is
unbiased by differences in measured pre-intervention covariates,
thus aiming to simulate a randomised trial using observational
data.29 30
We used the following baseline covariates (based on their
association with use of acute care at end of life20 31) to determine
propensity scores:
Age at death
Sex (male or female)
Comorbidity weighting—We used the Johns Hopkins
Adjusted Clinical Group method to adjust for comorbidity,
which has been validated for use in Canadian populations.32
Adjusted Clinical Group uses each patient’s age, sex, and
inpatient and outpatient diagnosis codes to categorise patients
into discrete groups—Adjusted Clinical Groups—where
each group has similar healthcare need, morbidity, and
expected resource consumption. We calculated Adjusted
Clinical Groups using the period two months before death
until 1.5 years before death. These Adjusted Clinical Groups
are given a weight, based on expected resource use, relative
to the average use of healthcare services of the population.
Cancer diagnosis—Cancer v non-cancer, determined using
the Adjusted Clinical Group Expanded Diagnostic Cluster
method.
Hospital and emergency department use before
intervention—This consisted of three separate variables:
mean number of hospitalisations, mean length of stay in
hospital, and the number of emergency department visits
during the period six months before death until 1.5 years
before death.
Exposed and unexposed patients were matched on three
variables:
Logit of the propensity score—We used callipers of width
equal to 0.2 of the standard deviation of the logit of the
propensity score, in keeping with prior research.33 34 We
estimated the propensity score using a logistic regression
model with exposure to a specialist team as the independent
variable. Predictor variables were the baseline covariates
described above.
Region and time—As described above, teams formed after
2009 were matched in the same region but a different time
(fiscal years 2007-09), whereas teams formed before 2009
were matched in a different region but the same time.
Homecare service type and time in homecare—Wematched
so that when homecare was used, the pair received the same
homecare service type and intent (ranging from end of life
(death expected within six months) to rehabilitation/acute
(full recovery expected)) and for the same amount of time
before death (matched within twoweeks of the first identified
homecare service date of the exposed patient in the year
before death).
Outcomes
The dichotomous outcomes were (a) being in hospital in the
last two weeks of life, (b) having an emergency department visit
in the last two weeks of life, and (c) dying in hospital (that is,
in an inpatient unit). These outcomes are common in palliative
care research and are widely used population-level indicators
of poor quality because they indicate over-aggressive care.35
Analytic approach
We estimated the relative risk of using acute care in the last two
weeks of life and dying in hospital in each of the 11 teams
separately and also the overall pooled effect (weighted).
Methods appropriate for matched samples were used in all cases
(for example, McNemar’s test for binary outcomes).34 36 We
conducted a sensitivity analysis to examine separately the pooled
results for the two approaches (historical and geographical) used
to identify a control group. Analysis was completed using
statistical software SAS v9. The study was approved by
McMaster University’s research ethics board.
Results
Our results showed variation across the 11 specialist palliative
care teams in terms of team size, geographies served, and
number of deaths in the catchment area (table 1⇓). Admissions
during fiscal years 2009-11 ranged from 90 to 830 patients
across the 11 teams. Team compositions varied as well: the
number of full time equivalent palliative care physicians per
team ranged from 0.5 to 11.5, and the number of nurses ranged
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from 1 to 8. The overall mean time from admission to a
specialist palliative care team to death was 73 days (standard
deviation 92 days).
The 11 specialist teams overall served 3912 patients who died
during fiscal years 2009-11 (exposed group), whereas the control
regions had 41 133 deaths (unexposed group) (table 2⇓). The
characteristics of the initial exposed and unexposed groups
differed greatly. For example, 79% of the exposed group had
cancer compared with 35% of the unexposed group (P<0.001).
Similarly, 78% of the exposed group received end of life
homecare services compared with 15% of the unexposed group
(P<0.001).
After propensity score matching, 3109 exposed patients were
matched to 3109 unexposed patients, and the characteristics of
these two groups were nearly identical: in both groups about
80% had cancer and 95% received some kind of homecare
service in the last year of life (78% received end of life homecare
services specifically, with similar mean time from first end of
life homecare service to death). Therefore, after propensity score
matching, the only observed systematic difference between the
two groups was their exposure to a specialist team.
Our pooled results show that 970 (31.2%) of the exposed group
was in hospital in the last two weeks of life compared with 1219
(39.3%) of the unexposed group (P<0.001). The pooled relative
risk of being in hospital in the last two weeks of life for exposed
versus unexposed patients was 0.68 (95% confidence interval
0.61 to 0.76), and six of the 11 specialist palliative care teams
had significantly lower relative risks (fig 1⇓). Similarly our
pooled results show that 896 (28.9%) of the exposed group had
an emergency department visit in the last two weeks of life
compared with 1070 (34.5%) of the unexposed group (P<0.001).
The pooled relative risk of having an emergency department
visit in the last two weeks of life was 0.77 (0.69 to 0.86), and
four of the 11 teams had significantly lower relative risk (fig
2⇓). Finally, across all teams fewer exposed patients died in
hospital compared with unexposed patients (503 (16.2%) v 887
(28.6%), P<0.01). The pooled relative risk of dying in hospital
for exposed versus unexposed groups was 0.46 (0.40 to 0.52),
and nine of the 11 teams had significantly lower relative risk
(fig 3⇓). The sensitivity analysis found consistent results
between the two approaches used to identify a control group
(historical and geographical) with the pooled results reported
above.
Discussion
Principal findings
Our pooled analysis of 11 specialist palliative care team
interventions strongly suggests that exposure to a palliative care
specialist team compared with usual care significantly reduces
the risk of being in hospital and going to an emergency
department in the last two weeks of life by a third and a quarter
respectively, and reduces the risk of dying in hospital by half.
These results suggest that even in real world, non-controlled
settings, with multiple differences between the specialist teams
and the geographies they serve, the core of the intervention
(nurses, palliative care physicians, and family physicians
working together to enhance usual palliative home care)
significantly reduces the use of acute care services in late life
and allows patients to die outside of hospital.
Strengths and limitations of the study
This study capitalised on a natural experiment in Ontario,
Canada, where multiple communities independently developed
specialist palliative care teams that differed in geography, team
size, and team organisation but had the same core teammembers
with the same roles as prior randomised trials. Thus, a key
contribution of this research was to explore whether the core
elements of the randomised trials would be effective at reducing
use of acute care, even when implemented with different team
compositions, while keeping the health system constant. A
unique strength of our study was the use of propensity score
matching in our observational data to reduce selection bias in
the control group. Pooling our data also allowed for a large
sample size and sufficient power, which was a limitation of
some previous trials.
Our study is limited in that propensity scores cannot adjust for
unmeasured covariates, such as patient preferences for hospital
care and availability of existing care giver support. Teams were
selected because their regions did not have major changes to
the palliative care health system during the comparison period,
though it is impossible to claim no changes at all. This study’s
teams served primarily cancer patients, which limits the
generalisability of the intervention effect to teams primarily
serving another disease group.
Comparison with other studies
Several trials have examined one community based palliative
care intervention using different team compositions, outcomes,
and health financing systems9-17 making it difficult to compare
and generalise; whereas our pooled analysis compared 11 teams
with different team compositions but using common outcomes
in the same healthcare financing system. Moreover, our pooled
study design supports the generalisability of the evidence that
community based specialist teams are effective at reducing acute
care use at the end of life in other countries. Despite different
healthcare financing policies, international research has
documented the same issues with end of life care in healthcare
systems as those documented in the “usual care” system in
Ontario: communication problems between settings and
providers, inadequate symptom control, unmet psychological
needs, and late referrals to specialist palliative care.19 37
The intervention’s effect likely results from the fact that—unlike
usual care at home, where palliative care providers vary
considerably in their accessibility, palliative care training, and
ability to coordinate care—the specialist palliative care team
can help to eliminate the variation and ensure that care is
accessible, coordinated, and provided by skilled workers. We
believe that the common features of the teams we studied (such
as 24/7 coverage and collaboration between nurses, specialist
physicians, and family physicians) are not unique to the
Canadian system and have similarities to existing models in
other countries. Compared with the UK, the community based
specialist palliative care teams in Ontario have similarities to
palliative care professionals working with hospice at home
services and palliative care specialist nurses (such as Marie
Curie nurses), as well as primary care teams using the Gold
Standard Framework.27 Indeed, our results are consistent with
observational work undertaken in the UK.38 Compared with the
US, the teams resemble home based, visiting hospice
programmes under the Medicare Hospice Benefit, though
patients in the Ontario do not need to forego other treatment for
their terminal illness to access the community specialist teams,
which is required in the US.39
Policy implications and conclusions
What services does the core team of providers deliver to patients
and families that helps reduce use of acute care services late in
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life? Care from the teams may help avoid unplanned use by
anticipating clinical problems early and making care
arrangements in advance. Teams expertly manage, monitor, and
rapidly respond to complex symptoms and changes in the
patient’s condition. When needed to support the patient or
prevent care giver burnout, they directly provide care or
advocate for additional care. Moreover, patients and families
can access the teams 24/7, a feature especially important on
evenings and weekends, when usual care provider’s offices are
typically closed. Indeed research shows that emergency
department visits and hospitalisations late in life occur because
of inadequate symptom control and failure to cope, among other
factors.40
Of the 11 specialist teams in our study, two (teams 5 and 6) did
not have any significant results across the outcomes, which
could indicate an ineffective intervention. For example, team 5
had a small team and a part time palliative care physician. Team
6 covered a large, rural area with a small team. However, the
non-significant results may also be due to the small sample sizes
for individual teams. Four teams (teams 4, 7, 9, and 11) showed
significantly positive effects of the intervention across all
outcomes despite their number of admissions, teams size, and
geography served varied considerably. This result emphasises
the importance of the core services the teams provided, which
was common across all teams, rather than the team composition
or model in which they practiced. The remaining teams
demonstrated significantly positive outcomes for one or two
outcomes, though we could not determine if acute care use in
the non-significant outcomes were medically appropriate.
Conclusions
Using propensity scores to simulate a randomised trial of a
specialist palliative care team intervention, our pooled analysis
suggests that even in real world, non-controlled settings, where
specialist teams vary in team composition and geography served,
the specialist team intervention supports more patients to die
outside of hospitals and avoid late-life use of acute services
compared with usual care. The impact of specialist team
interventions on the various non-cancer diagnoses in the
community should be investigated further. Future research
should also determine the intervention’s impact on other health
system outcomes, such as primary care capacity or patient and
provider satisfaction, as well as assess how the variation among
teams (such as role of additional team members or models of
care) are associated with these outcomes.
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Tables
Table 1| Characteristics of the 11 palliative care teams in study
No of full time equivalent team members
Mean (SD) time in
team’s care before
death (days)
Date team
established
No (%) of rural
admissions to
team*
No of
admissions to
team in
2009-11
No of deaths in
comparison
region in 2009-11Team Other†Nurses
Palliative care
physicians
28168 (79)2009≤5 (0.6)83016 2431
1.52197 (117)2009≤5 (0.9)2212 2402
0.61183 (102)20099 (6.3)1441 5343
12166 (86)2009≤5 (3.2)1251 6704
0.210.572 (85)2009≤5 (1.9)1053 1025
1.22293 (97)200958 (64.4)901 1856
5.9111.571 (83)1986≤5 (0.1)6767 6297
12282 (93)200741 (8.2)4975 2648
1.731.373 (98)1998100 (12.9)7758409
2.510.660 (96)200436 (13.4)26873710
4.72663 (102)197966 (36.5)18168911
N/AN/AN/A73 (92)N/A324 (8.3)3 91241 133Pooled
*Community population <10 000.
†Other team members vary by team, including psychosocial worker, bereavement counselor, social worker, administrative support, etc.
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Table 2| Characteristics of patients served by 11 specialist palliative care teams (exposed) and patients who received usual care (unexposed)
before and after propensity score matching. Values are numbers (percentages) of patients unless stated otherwise
After propensity score matchingBefore propensity score matching
Characteristics UnexposedExposedUnexposedExposed
3 1093 10941 1333 912No of patients (pooled across the teams)
74 (63 to 83)75 (64 to 84)80 (69 to 87)75 (64 to 84)Median (IQR) age at death (years)
2 481 (79.8)2 469 (79.4)14 443 (35.1)3 073 (78.6)Cancer diagnosis
1 609 (51.8)1 600 (51.5)20 895 (50.8)2 032 (51.9)Women
1 500 (48.2)1 509 (48.5)20 238 (49.2)1 880 (48.1)Men
6.21 (3.93)6.20 (3.98)5.12 (4.09)6.30 (4.04)Mean (SD) adjusted clinical group comorbidity weighting
Home care service type:
2 409 (77.5)2 409 (77.5)6 208 (15.1)3 041 (77.7)End of life
145 (4.7)145 (4.7)3 408 (8.3)210 (5.4)Long term supportive
278 (8.9)278 (8.9)7 692 (18.7)328 (8.4)Maintenance
106 (3.4)106 (3.4)6 478 (15.7)157 (4.0)Rehabilitation or acute care
171 (5.5)171 (5.5)17 347 (42.2)176 (4.5)None
Mean (SD) time from first receipt of most severe home care service type
(days before death):
79.23 (102.02)79.32 (102.05)15.47 (56.48)86.18 (107.29)End of life
37.96 (95.92)27.84 (83.51)23.92 (81.17)31.00 (87.25)Long term supportive
81.64 (131.06)83.55 (132.16)63.68 (124.80)82.02 (131.69)Maintenance
79.29 (112.60)80.12 (114.96)69.70 (113.27)76.05 (113.98)Rehabilitation or acute care
1.40 (1.95)1.36 (1.96)1.16 (2.10)1.43 (2.11)Mean (SD) No of prior emergency department visits
6.84 (14.17)6.73 (14.85)7.18 (22.23)7.53 (17.09)Mean (SD) prior hospital length of stay (days)
0.76 (1.15)0.70 (1.07)0.56 (1.04)0.75 (1.14)Mean (SD) No of prior hospital visits
Income quintile*:
772 (24.8)536 (17.2)10 288 (25.0)668 (17.1)1 (lowest)
703 (22.6)605 (19.5)9 053 (22.0)746 (19.1)2
604 (19.4)550 (17.7)7 565 (18.4)720 (18.4)3
585 (18.8)675 (21.7)7 460 (18.1)872 (22.3)4
437 (14.1)743 (23.9)6 555 (15.9)906 (23.2)5 (highest)
*Community income quintiles were reported from Census data using postal codes.
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Figures
Fig 1 Relative risk of being in hospital in the last two weeks of life for exposed patients (care from specialist palliative care
team) and unexposed patients (usual care)
Fig 2 Relative risk of an emergency department visit in the last two weeks of life for exposed patients (care from specialist
palliative care team) and unexposed patients (usual care)
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Fig 3Relative risk of dying in hospital for exposed patients (care from specialist palliative care team) and unexposed patients
(usual care)
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